Ji Pharmaceutical Holdings Group Co., Ltd. (hereinafter referred to as "the Company") aims to accurately and objectively reflect its financial status and operational results. In accordance with the "Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operations of GEM Listed Companies" and "Enterprise Accounting Standards," the Company has conducted an assessment and analysis of assets requiring impairment provisions within the scope of the consolidated financial statements. The following is the announcement of the relevant situation:
I. Overview of the Provision for Asset Impairment
(1) Reasons for the Provision for Asset Impairment
According to the relevant provisions of the "Enterprise Accounting Standards" and the Company's accounting policies, the Company has conducted a review and analysis of various assets within the consolidation scope as of December 31, 2024, and has tested them by asset category, making provisions for impairment on certain assets that may incur credit or asset impairment losses.
(2) Details of the Provision for Asset Impairment
The Company and its subsidiaries have conducted a comprehensive review and impairment testing of assets that may show signs of impairment as of the end of December 2024. The details of the impairment provisions are as follows:
| Item | Amount (RMB 10,000) |
|---|---|
| Bad debt loss on notes receivable (losses indicated with "-") | 17.68 |
| Bad debt loss on accounts receivable (losses indicated with "-") | -793.61 |
| Bad debt loss on other receivables (losses indicated with "-") | -275.84 |
| Inventory write-down loss (losses indicated with "-") | -2,603.44 |
| Impairment loss on other current assets (losses indicated with "-") | -1,952.64 |
| Impairment loss on other equity investments (losses indicated with "-") | -6,676.24 |
| Impairment loss on fixed assets (losses indicated with "-") | -7,613.82 |
| Impairment loss on construction in progress (losses indicated with "-") | -6,736.22 |
| Impairment loss on intangible assets (losses indicated with "-") | -1,920.65 |
| Impairment loss on goodwill (losses indicated with "-") | -7,755.65 |
| Total | -36,310.43 |